Edition:
India

People: AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

27.25USD
22 Apr 2019
Change (% chg)

$0.11 (+0.41%)
Prev Close
$27.14
Open
$27.02
Day's High
$27.27
Day's Low
$27.02
Volume
1,738
Avg. Vol
83,334
52-wk High
$36.08
52-wk Low
$19.77

Wehrwein, Sven 

Mr. Sven A. Wehrwein, CPA is Independent Director of the AtriCure Inc. Mr. Wehrwein has been an independent financial consultant to emerging companies since 1999. During his 35-plus years in accounting and finance, Mr. Wehrwein has experience as a certified public accountant (inactive), investment banker to emerging-growth companies, chief financial officer and audit committee chair. Mr. Wehrwein currently serves on the board of directors of Proto Labs, Inc., a custom prototype manufacturer, and SPS Commerce, Inc., a supply-chain management software company, both of which are publicly traded companies. Mr. Wehrwein has also served on the boards of directors for a number of other medical device and high growth companies including tenures on the boards of Cogentix Medical, Inc., Compellent Technologies, Inc., Synovis Life Technologies, Inc. and Vital Images, Inc. Mr. Wehrwein holds a B.S. in Business from Loyola University of Chicago and an M.S. in Management from the Sloan School, MIT.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 124,982
Long-Term Incentive Plans, USD --
All Other, USD 66,044
Fiscal Year Total, USD 191,026

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Scott Drake

194,982

Michael Carrel

4,156,350

M. Andrew Wade

1,075,720

Douglas Seith

1,841,050

Justin Noznesky

1,023,000

Salvatore Privitera

1,624,280
As Of  31 Dec 2017